
Ryan N. Henderson
Examiner (ID: 2057, Phone: (571)270-1430 , Office: P/3779 )
| Most Active Art Unit | 3795 |
| Art Unit(s) | 3739, 3795, 3779 |
| Total Applications | 931 |
| Issued Applications | 516 |
| Pending Applications | 102 |
| Abandoned Applications | 329 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10340689
[patent_doc_number] => 20150225695
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-13
[patent_title] => 'METHOD OF OBTAINING CHICKEN EMBRYONIC STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 14/585955
[patent_app_country] => US
[patent_app_date] => 2014-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13920
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14585955
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/585955 | METHOD OF OBTAINING CHICKEN EMBRYONIC STEM CELLS | Dec 29, 2014 | Abandoned |
Array
(
[id] => 10491552
[patent_doc_number] => 20150376572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-31
[patent_title] => 'ADIPOSE-DERIVED STEM CELLS AND LATTICES'
[patent_app_type] => utility
[patent_app_number] => 14/581956
[patent_app_country] => US
[patent_app_date] => 2014-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 99
[patent_figures_cnt] => 99
[patent_no_of_words] => 83227
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14581956
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/581956 | ADIPOSE-DERIVED STEM CELLS AND LATTICES | Dec 22, 2014 | Abandoned |
Array
(
[id] => 10274134
[patent_doc_number] => 20150159132
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-11
[patent_title] => 'TECHNOLOGY FOR CELL TRANSDIFFERENTIATION'
[patent_app_type] => utility
[patent_app_number] => 14/568597
[patent_app_country] => US
[patent_app_date] => 2014-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9104
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14568597
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/568597 | TECHNOLOGY FOR CELL TRANSDIFFERENTIATION | Dec 11, 2014 | Abandoned |
Array
(
[id] => 11902137
[patent_doc_number] => 09771561
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-26
[patent_title] => 'Method of making primate cells expressing apelin receptor that have mesangioblast potential'
[patent_app_type] => utility
[patent_app_number] => 14/569130
[patent_app_country] => US
[patent_app_date] => 2014-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 18
[patent_no_of_words] => 7884
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14569130
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/569130 | Method of making primate cells expressing apelin receptor that have mesangioblast potential | Dec 11, 2014 | Issued |
Array
(
[id] => 10422831
[patent_doc_number] => 20150307843
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-29
[patent_title] => 'METHOD TO OBTAIN HEMATOPOIETIC STEM CELLS USING THREE-DIMENSIONAL INDUCING SYSTEM'
[patent_app_type] => utility
[patent_app_number] => 14/562230
[patent_app_country] => US
[patent_app_date] => 2014-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4211
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14562230
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/562230 | METHOD TO OBTAIN HEMATOPOIETIC STEM CELLS USING THREE-DIMENSIONAL INDUCING SYSTEM | Dec 4, 2014 | Abandoned |
Array
(
[id] => 10204692
[patent_doc_number] => 20150089680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-26
[patent_title] => 'Human Lambda Light Chain Mice'
[patent_app_type] => utility
[patent_app_number] => 14/561867
[patent_app_country] => US
[patent_app_date] => 2014-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 26446
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14561867
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/561867 | Human lambda light chain mice | Dec 4, 2014 | Issued |
Array
(
[id] => 10390170
[patent_doc_number] => 20150275177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-01
[patent_title] => 'Methods For Generating Pluripotent Stem Cell-Derived Brown Fat Cells'
[patent_app_type] => utility
[patent_app_number] => 14/554019
[patent_app_country] => US
[patent_app_date] => 2014-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 42025
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14554019
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/554019 | Methods For Generating Pluripotent Stem Cell-Derived Brown Fat Cells | Nov 24, 2014 | Abandoned |
Array
(
[id] => 10265155
[patent_doc_number] => 20150150152
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-28
[patent_title] => 'Chimeric Retinoid X Receptors and Their Use in a Novel Ecdysone Receptor-Based Inducible Gene Expression System'
[patent_app_type] => utility
[patent_app_number] => 14/551247
[patent_app_country] => US
[patent_app_date] => 2014-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 30158
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14551247
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/551247 | Chimeric Retinoid X Receptors and Their Use in a Novel Ecdysone Receptor-Based Inducible Gene Expression System | Nov 23, 2014 | Abandoned |
Array
(
[id] => 12347550
[patent_doc_number] => 09951353
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-24
[patent_title] => Engineering neural stem cells using homologous recombination
[patent_app_type] => utility
[patent_app_number] => 15/035958
[patent_app_country] => US
[patent_app_date] => 2014-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 56
[patent_no_of_words] => 70690
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15035958
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/035958 | Engineering neural stem cells using homologous recombination | Nov 13, 2014 | Issued |
Array
(
[id] => 11436354
[patent_doc_number] => 20170037376
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-09
[patent_title] => 'METHOD FOR PREPARING INDUCED PLURIPOTENT STEM CELL, COMPOSITION USED IN METHOD, AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/036285
[patent_app_country] => US
[patent_app_date] => 2014-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 22875
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15036285
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/036285 | METHOD FOR PREPARING INDUCED PLURIPOTENT STEM CELL, COMPOSITION USED IN METHOD, AND USES THEREOF | Nov 11, 2014 | Abandoned |
Array
(
[id] => 10580953
[patent_doc_number] => 09303072
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-05
[patent_title] => 'Method of stimulating an immune response using a pseudotyped lentivirus'
[patent_app_type] => utility
[patent_app_number] => 14/532371
[patent_app_country] => US
[patent_app_date] => 2014-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 35
[patent_no_of_words] => 30924
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14532371
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/532371 | Method of stimulating an immune response using a pseudotyped lentivirus | Nov 3, 2014 | Issued |
Array
(
[id] => 11794370
[patent_doc_number] => 09404124
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-02
[patent_title] => 'Method of producing induced pluripotent stem cells using inhibitors of P53'
[patent_app_type] => utility
[patent_app_number] => 14/533080
[patent_app_country] => US
[patent_app_date] => 2014-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 39
[patent_no_of_words] => 28101
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14533080
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/533080 | Method of producing induced pluripotent stem cells using inhibitors of P53 | Nov 3, 2014 | Issued |
Array
(
[id] => 10291014
[patent_doc_number] => 20150176013
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-25
[patent_title] => 'THERAPEUTIC USES OF GENOME EDITING WITH CRISPR/Cas SYSTEMS'
[patent_app_type] => utility
[patent_app_number] => 14/509787
[patent_app_country] => US
[patent_app_date] => 2014-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 50
[patent_no_of_words] => 42595
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14509787
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/509787 | THERAPEUTIC USES OF GENOME EDITING WITH CRISPR/Cas SYSTEMS | Oct 7, 2014 | Abandoned |
Array
(
[id] => 9812467
[patent_doc_number] => 20150024412
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-22
[patent_title] => 'Humanized FcgammaR Mice'
[patent_app_type] => utility
[patent_app_number] => 14/508782
[patent_app_country] => US
[patent_app_date] => 2014-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 17653
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14508782
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/508782 | Isolated cells from humanized FcγR mice | Oct 6, 2014 | Issued |
Array
(
[id] => 11047760
[patent_doc_number] => 20160244718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-25
[patent_title] => 'REPROGRAMMING OF PLURIPOTENT STEM CELLS FOR IMPROVED CONTROL OF THEIR DIFFERENTIATION PATHWAYS'
[patent_app_type] => utility
[patent_app_number] => 15/026201
[patent_app_country] => US
[patent_app_date] => 2014-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 29575
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15026201
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/026201 | REPROGRAMMING OF PLURIPOTENT STEM CELLS FOR IMPROVED CONTROL OF THEIR DIFFERENTIATION PATHWAYS | Oct 1, 2014 | Abandoned |
Array
(
[id] => 9917212
[patent_doc_number] => 20150072417
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-12
[patent_title] => 'METHOD OF NUCLEAR REPROGRAMMING'
[patent_app_type] => utility
[patent_app_number] => 14/502374
[patent_app_country] => US
[patent_app_date] => 2014-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 13065
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14502374
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/502374 | METHOD OF NUCLEAR REPROGRAMMING | Sep 29, 2014 | Abandoned |
Array
(
[id] => 9930861
[patent_doc_number] => 20150079052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-19
[patent_title] => 'Methods for amelioration of autoimmune disease using stem cells transduced with T cell receptors from IL-10 secreting T cells'
[patent_app_type] => utility
[patent_app_number] => 14/501446
[patent_app_country] => US
[patent_app_date] => 2014-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 12228
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14501446
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/501446 | Methods for amelioration of autoimmune disease using stem cells transduced with T cell receptors from IL-10 secreting T cells | Sep 29, 2014 | Abandoned |
Array
(
[id] => 10201552
[patent_doc_number] => 20150086541
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-26
[patent_title] => 'Methods of Cytotoxic Gene Therapy To Treat Tumors'
[patent_app_type] => utility
[patent_app_number] => 14/490940
[patent_app_country] => US
[patent_app_date] => 2014-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10724
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14490940
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/490940 | Methods of cytotoxic gene therapy to treat tumors | Sep 18, 2014 | Issued |
Array
(
[id] => 9934278
[patent_doc_number] => 20150082471
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-19
[patent_title] => 'METHOD FOR CULTURING AVIAN GONOCYTES'
[patent_app_type] => utility
[patent_app_number] => 14/488185
[patent_app_country] => US
[patent_app_date] => 2014-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6388
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14488185
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/488185 | Method for culturing avian gonocytes | Sep 15, 2014 | Issued |
Array
(
[id] => 9792759
[patent_doc_number] => 20150004703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-01
[patent_title] => 'SINGLE LENTIVIRAL VECTOR SYSTEM FOR INDUCED PLURIPOTENT (IPS) STEM CELLS DERIVATION'
[patent_app_type] => utility
[patent_app_number] => 14/486750
[patent_app_country] => US
[patent_app_date] => 2014-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 28884
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14486750
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/486750 | SINGLE LENTIVIRAL VECTOR SYSTEM FOR INDUCED PLURIPOTENT (IPS) STEM CELLS DERIVATION | Sep 14, 2014 | Abandoned |